Adaptin Bio, Inc. Files 2024 Annual Report
Ticker: APTN · Form: 10-K · Filed: Apr 15, 2025 · CIK: 1938571
| Field | Detail |
|---|---|
| Company | Adaptin Bio, Inc. (APTN) |
| Form Type | 10-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, 10-K, biotechnology
TL;DR
Adaptin Bio (fka Unite Acquisition 1 Corp) filed its 2024 10-K. Details on biz & financials.
AI Summary
Adaptin Bio, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, formerly known as Unite Acquisition 1 Corp. until July 19, 2022, is incorporated in Delaware and headquartered in Charlotte, North Carolina. The filing provides a comprehensive overview of the company's business, financial condition, and results of operations for the year.
Why It Matters
This filing provides investors and stakeholders with crucial financial and operational details for Adaptin Bio, Inc. for the 2024 fiscal year, enabling informed decision-making.
Risk Assessment
Risk Level: low — This is a standard annual report filing and does not contain new material risks.
Key Numbers
- 000-56583 — SEC File Number (Commission file number for Adaptin Bio, Inc.)
- 88-1566415 — EIN (Employer Identification Number)
Key Players & Entities
- Adaptin Bio, Inc. (company) — Registrant
- Unite Acquisition 1 Corp. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-04-15 (date) — Filing date
- Charlotte, North Carolina (location) — Principal executive offices
FAQ
What is the primary business of Adaptin Bio, Inc.?
The filing indicates Adaptin Bio, Inc. is involved in the biotechnology sector, though specific details of its operations are not elaborated in the provided header information.
When did Adaptin Bio, Inc. change its name from Unite Acquisition 1 Corp.?
The company changed its name from Unite Acquisition 1 Corp. on July 19, 2022.
What is the fiscal year end for Adaptin Bio, Inc.?
The fiscal year end for Adaptin Bio, Inc. is December 31.
Where are Adaptin Bio, Inc.'s principal executive offices located?
Adaptin Bio, Inc.'s principal executive offices are located at 3540 Toringdon Way, Suite 200, #250, Charlotte, North Carolina, 28277.
What is the SEC file number for Adaptin Bio, Inc.?
The SEC file number for Adaptin Bio, Inc. is 000-56583.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding ADAPTIN BIO, INC. (APTN).